Emotra AB is a research based medical device company. We offer the psychiatric care and objective and quantitative electrodermal test of hyporeactivity for the evaluation of suicide risk.


Introduction film
06 April

A short update – Successful meeting for Emotra in Florence

Emotra’s management team has just returned from several days of…

Read more
31 March

Consensus meeting supports plans to launch EDOR®

The Emotra clinical multicentre study, EUDOR-A, which was started during…

Read more
13 March

European Commission Horizon 2020 – application rejected

The European Commission, EC, has rejected Emotra’s application, submitted in…

Read more
15 February

Emotra AB (publ) Year-end report January 1 – December 31, 2016

The Board and CEO of Emotra AB herewith present the…

Read more
29 January

Emotra has submitted a new application for a grant from the EU Horizon 2020 programme

Emotra has submitted a new application to the European Commission…

Read more
30 November

Emotra’s application is given the “Seal of Excellence”

On November 28, Emotra announced that the Company’s Horizon 2020…

Read more